Crossasia Biotech Private Limited - Company Profile

It is a paper private limited company based in Gird, Madhya Pradesh, India, established in 2024.
2024 Gird, Madhya Pradesh, India Active
Last Updated:
Access Report
About Crossasia Biotech Private Limited

Crossasia Biotech Private Limited, a active private limited company, was established on 28 October 2024 in Gird, Madhya Pradesh, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002MP2024PTC073403. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.50 M.

Its leadership includes Sagar Khatuja (Director), Hardutt Singh (Director), Pankaj Bhardwaj (Director). Past directors included Anil Kukreja, Divya Kukreja. It is based at Survey No 488, Girwai Industrial, Area, Beldar Ka Pura, Gird, Madhya Pradesh, 474001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002MP2024PTC073403

  • Registration Number

    073403

  • Incorporation Date

    28 October 2024

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 1 Year 3 Months
Company report

Crossasia Biotech Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Crossasia Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Crossasia Biotech Private Limited?
Current Directors
Name Designation Appointment Date Status
Sagar Khatuja Director 28 Oct 2024 Current
Hardutt Singh Director 16 Apr 2025 Current
Pankaj Bhardwaj Director 16 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 19 Apr 2025 Past
Pramod Abcsdd Director 19 Apr 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Crossasia Biotech.

Enhance accessibility to Crossasia Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Crossasia Biotech revenue growth over time
Crossasia Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Crossasia Biotech?

Unlock access to Crossasia Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Crossasia Biotech?

Unlock and access historical data on people associated with Crossasia Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Crossasia Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crossasia Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Crossasia Biotech
Recent Activity within the Organization
  • Director Appointment

    The activity Hardutt Singh was appointed as a Director was appointed as a Director on 16 Apr 2025 & has been associated with this company since 10 months 3 days . was completed.

  • Director Appointment

    Progress on Pankaj Bhardwaj was appointed as a Director was appointed as a Director on 16 Apr 2025 & has been associated with this company since 10 months 3 days . was documented.

  • Director Appointment

    Sagar Khatuja was appointed as a Director was appointed as a Director on 28 Oct 2024 & has been associated with this company since 1 year 3 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Crossasia Biotech Private Limited was registered on 28 Oct 2024 with Roc Gwalior & aged 1 year 3 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Crossasia Biotech Private Limited?

The CIN of Crossasia Biotech Private Limited is U21002MP2024PTC073403.

Where is Crossasia Biotech Private Limited headquartered?

Crossasia Biotech Private Limited is headquartered at Survey No 488, Girwai Industrial, Area, Beldar Ka Pura, Gird, Madhya Pradesh, 474001.

When was Crossasia Biotech Private Limited incorporated?

Crossasia Biotech Private Limited was incorporated on 28 October 2024.

Who are the current directors of Crossasia Biotech Private Limited?

The current directors of Crossasia Biotech Private Limited are

What is the primary industry of Crossasia Biotech Private Limited?

The primary industry of Crossasia Biotech Private Limited is Paper.

Is Crossasia Biotech Private Limited a listed company?

Crossasia Biotech Private Limited is unlisted.

What is the capital structure of Crossasia Biotech Private Limited?

The authorized capital of Crossasia Biotech Private Limited is ₹1.50 M, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available